BioSig Technologies, Inc. (BSGM)
Automate Your Wheel Strategy on BSGM
With Tiblio's Option Bot, you can configure your own wheel strategy including BSGM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BSGM
- Rev/Share 0.0013
- Book/Share 0.1318
- PB 30.8365
- Debt/Equity 0.0221
- CurrentRatio 2.374
- ROIC -4.4334
- MktCap 125933334.0
- FreeCF/Share -0.2193
- PFCF -27.623
- PE -8.5771
- Debt/Assets 0.0136
- DivYield 0
- ROE -35.3007
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
Published: July 14, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM” or the “Company”), is excited to announce a critical step toward becoming one of the first fully regulated Real-World Asset (“RWA”) tokenization companies trading on a major United States exchange: Streamex has engaged Compliance Exchange Group (CXG) to lead and manage the acquisition of a specifi.
Read More
CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
Published: July 14, 2025 by: Business Wire
Sentiment: Neutral
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--Please replace the release dated July 11, 2025 with the following corrected version due to revisions to details of Russell Starr's appointment and biography. During this period, Mr. Starr was not the Chief Executive Officer of the Company, but instead served as Head of Capital Markets Consultant at DeFi Technologies. The updated release reads: BIOSIG & STREAMEX APPOINT DEFI EXPERT AND VISIONARY, RUSSELL STARR AS STRATEGIC ADVISOR B.
Read More
BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
Published: July 11, 2025 by: Business Wire
Sentiment: Neutral
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across, defi, traditional finance and emerging sectors. A former executive on Bay Street and res.
Read More
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
Published: June 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Trevor Bacon and Kellan Grenier, co-founders of Parcl, as Strategic Advisors. Together, they bring deep expertise at the intersection of decentralized finance, synthetic asset creation, and real-world asset tokenization.
Read More
BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer
Published: May 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the “combined company”), which today acquired Streamex Exchange Corporation (“Streamex”) as its wholly owned subsidiary, announced the appointment of Mitch Williams, CFA, as Chief Investment Officer, significantly bolstering the combined company's leadership team and advancing its mission to tokenize real world assets and bring commodity markets on-chain.
Read More
BioSig Stock Surges Following Share Exchange Deal With Streamex
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
BSGM merges with Streamex to enter the blockchain space, aiming to revolutionize commodity tokenization and expand its footprint in digital asset markets.
Read More
BSGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of BioSig Technologies, Inc. Is Fair to Shareholders
Published: May 26, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of BioSig Technologies, Inc. (NASDAQ: BSGM) and Streamex Exchange Corporation is fair to BioSig shareholders. Upon completion of the proposed transaction, current BioSig shareholders and holders of common stock equivalents will hold 25% of the fully diluted BioSig common stock outstanding. Halper Sadeh encourages BioSig shareholders to click here to learn more about their legal rights a.
Read More
Biosig Technologies (BSGM) Upgraded to Buy: What Does It Mean for the Stock?
Published: April 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Biosig Technologies (BSGM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce that its common stock will continue trading on The Nasdaq Capital Market (“Nasdaq”).
Read More
About BioSig Technologies, Inc. (BSGM)
- IPO Date 2014-10-31
- Website https://www.biosig.com
- Industry Medical - Devices
- CEO Anthony Amato
- Employees 5